Pfizer submits a request to the US government to allow the emergency authorization of the COVID-19 vaccine for children ages 5-11.
Last month, Pfizer submitted research to the US Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children. Pfizer says it will also submit the data to the European Medicines Agency and other regulators.
In Israel, 55% of those ages 12-15 have received at least one dose of the COVID vaccine, and 43% have received two doses. If the FDA approves the vaccine for children ages 5-11, the Israeli Health Ministry is expected to follow suit.